Company / Operating Margin
Entrada Therapeutics, Inc. Operating Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
22.3%
FY2025
5-year range
-75.4% / 22.3%
FY2023-FY2025
Trend
+1010.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed +1010% YoY in FY2025, a notable deviation from the 2-year average annual change of +553%.
Based on SEC 10-K filings.
22.3% in FY2025.
Improved from -75.4% to 22.3% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 1010.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.03 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 22.3% | +1010.2% |
| FY2024 | -2.5% | +96.7% |
| FY2023 | -75.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026